Trials / Completed
CompletedNCT02183220
Efficacy and Tolerability of Metamizol in Patients With Episodic Moderate Headache
A Randomised, Double Blind, Placebo- and Active-controlled Parallel Group Study Investigating the Efficacy and Tolerability of Metamizol 0.5 g and 1.0 g in Patients With Episodic Moderate Tension Headache.
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 417 (actual)
- Sponsor
- Boehringer Ingelheim · Industry
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
The objective of the study was to evaluate the efficacy, safety and tolerability of a single peroral dose of 0.5 g and 1.0 g metamizol relative to placebo and 1.0 g acetylsalicylic acid in 2 episodes of moderate tension headache.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Metamizol | |
| DRUG | Acetylsalicylic acid (ASA) | |
| DRUG | Metamizol placebo | |
| DRUG | ASA placebo |
Timeline
- Start date
- 1998-10-01
- Primary completion
- 1999-07-01
- First posted
- 2014-07-08
- Last updated
- 2014-07-08
Source: ClinicalTrials.gov record NCT02183220. Inclusion in this directory is not an endorsement.